)
Visual
test
Bioventus
Bioventus (BVS) investor relations material
Bioventus 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary14 Jan, 2026
Company transformation and strategic focus
Underwent significant transformation, improving prioritization, execution, and reducing leverage.
Achieved revenue growth above market, peer-leading gross margins in the mid-70s%, and expanded EBITDA margins by 700 basis points.
Generated over $100 million in operating cash flow in the last two years, setting a strong foundation for future growth.
Aims to become a leading med tech company exceeding $1 billion in size, with durable growth and high margins.
Divested non-core assets to sharpen commercial execution and reduce debt.
Growth drivers and innovation
Four main growth drivers: ultrasonics, international, peripheral nerve stimulation (PNS), and platelet-rich plasma (PRP).
PNS platform recently received FDA clearance and is entering full launch, offering unique technology advantages.
PRP business leverages existing salesforce, offers single-spin convenience, and enables customizable treatments.
Ultrasonics is the fastest-growing segment, with technology aimed at becoming the standard of care in spinal surgery.
International expansion targets EMEA and APAC with a disciplined, market-specific approach.
Portfolio evolution and investment priorities
Portfolio structured into core, expansion, and emerging growth platforms, each with distinct roles in growth and profitability.
Core portfolio (HA, BGS, Fracture Care) delivers strong sales, margins, and cash flow, growing above market.
Expansion areas include ultrasonics and international markets, expected to become more material with targeted investments.
Investment priorities include milestone-based PNS sales force expansion, increased international resources, and R&D for PNS and ultrasonics.
Strategic marketing to raise awareness of clinical and economic benefits, with a strict ROIC lens guiding investments.
PNS competitive strategy against Boston Scientific?
Ultrasonics path to standard of care?
Drivers of 2026 cash flow acceleration?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- AGCO
Q4 2025 delivered higher margins and record cash flow, with 2026 outlook stable and focused on efficiency. - 531768
Q3 FY26 revenue and profit rose strongly YoY, supported by global expansion and steady margins. - AURIONPRO
26% revenue growth, strong margins, major wins, and AI-driven expansion mark the period. - 513023
Net profit rose 83.5% QoQ to ₹325.7 Cr, driven by strong energy and mining results. - APOTEA
Q4 revenue rose 7% but margins fell; full-year growth strong, driven by Rx and new investments. - HSY
2026 outlook targets 4%-5% sales growth, margin recovery, and 30%-35% EPS growth. - MTSI
Revenue up 24.5% year-over-year, with strong margins and positive Q2 outlook. - BSIG
Record AUM, strong net inflows, and margin expansion led to all-time high ENI EPS. - SPH
Q1 FY2026 net income and Adjusted EBITDA surged on higher volumes, acquisitions, and colder weather. - AFL
Adjusted EPS and ROE stable; strong capital, high persistency, and 2026 guidance reaffirmed.
Next Bioventus earnings date
Q4 202510 Mar, 2026
Bioventus
Next Bioventus earnings date
Q4 202510 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Bioventus Inc is a medical device company focused on developing and commercializing clinical and surgical solutions for orthopedics. The company provides products for pain treatments, bone healing, and joint preservation. It serves healthcare providers, hospitals, and ambulatory surgical centers across the United States and international markets. Bioventus Inc is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage